YS Biopharma Co., Ltd. announced that it has entered into a share purchase agreement with an institutional investor to issue 95,269,762 ordinary shares at an issue price of $0.41986 per Share for the gross proceeds of $39,999,962.27332 on February 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 USD | +2.56% |
|
-14.00% | +17.42% |
Jun. 10 | Lakeshore Biopharma Co., Ltd Announces Executive Changes | CI |
May. 28 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.42% | 113M | |
+2.22% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |
- Stock Market
- Equities
- LSB Stock
- News LakeShore Biopharma Co., Ltd
- YS Biopharma Co., Ltd. announced that it expects to receive $39.999962 million in funding